<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T11:32:47Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/164841" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/164841</identifier><datestamp>2025-11-19T10:53:31Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478917</setSpec><setSpec>col_2072_478923</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Heterodi- (Fe, Pd/Pt) and heterotrimetallic (Fe2, Pd) complexes derived from 4-(ferrocenylmethyl)-N-(2-methoxyethyl)-3,5-diphenylpyrazole as potential antitumoral agents</dc:title>
   <dc:creator>Guillén, E.</dc:creator>
   <dc:creator>González Gazulla, Asensio</dc:creator>
   <dc:creator>López Martínez, Ma. Concepción</dc:creator>
   <dc:creator>Basu, Pradipta K.</dc:creator>
   <dc:creator>Ghosh, A.</dc:creator>
   <dc:creator>Font Bardia, Ma. Mercedes</dc:creator>
   <dc:creator>Calvis, C.</dc:creator>
   <dc:creator>Messeguer i Peypoch, Ramon</dc:creator>
   <dc:subject>Compostos metàl·lics</dc:subject>
   <dc:subject>Pal·ladi (Element químic)</dc:subject>
   <dc:subject>Platí</dc:subject>
   <dc:subject>Tumors</dc:subject>
   <dc:subject>Metallic composites</dc:subject>
   <dc:subject>Palladium</dc:subject>
   <dc:subject>Platinum</dc:subject>
   <dc:subject>Tumors</dc:subject>
   <dc:description>The study of the reactivity of the pyrazole derivative 1-[MeO-(CH2)2]-3,5-Ph2-4-(CH2Fc) (C3N2) (1, Fc = ferrocenyl) with Na2[PdCl4], Pd(OAc)2, and [MCl2(dmso)2] (M = Pd or Pt,dmso = dimethyl sulfoxide) has allowed us to isolate trans-[Pd{κ-N-(1-{MeO(CH2)2}-3,5-Ph2-4-{CH2Fc} {C3N2})}2Cl2] (2), [Pd{κ2-C,N(1-{MeO(CH2)2}-3-{C6H4}-5-Ph-{C3N2})}{κ-N-(1-{MeO(CH2)2}-3,5-Ph2-4-{CH2Fc} {C3N2})}Cl] (3), [Pd{κ2-C,N(1-{MeO(CH2)2}-3-{C6H4}-4-{CH2Fc}-5-Ph-{C3N2})}Cl-(PPh3)] (4), and the trans (5) and cis (6) isomers of [Pt{κ-N-(1-{MeO(CH2)2}-3,5-Ph24-{CH2Fc} {C3N2})}Cl2(dmso)]. Compound 1 acts as a N (in 2, 5, and 6) or (C,N) donor ligand (in 4) and shows both binding modes in 3. The cytotoxic assessment of 1 6 against MCF7, MDA-MB231 (breast), and HCT-116 (colon) cancer cell lines reveal that (1) 1 is more potent than 1-[MeO(CH2)2]-3,5-Ph2-(C3HN2) (V), (2) 2 6 have cytotoxic activity, (3) 2 and 3 are less active than 4 6, and (4) 6 is the most potent compound against the three cancer cell lines.</dc:description>
   <dc:date>2020-06-08T18:10:14Z</dc:date>
   <dc:date>2020-06-08T18:10:14Z</dc:date>
   <dc:date>2015-07-07</dc:date>
   <dc:date>2020-06-08T18:10:15Z</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
   <dc:identifier>1434-1948</dc:identifier>
   <dc:identifier>https://hdl.handle.net/2445/164841</dc:identifier>
   <dc:identifier>653888</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Versió postprint del document publicat a: https://doi.org/10.1002/ejic.201500520</dc:relation>
   <dc:relation>European Journal of Inorganic Chemistry, 2015, vol. 2015, num. 22, p. 3781-3791</dc:relation>
   <dc:relation>https://doi.org/10.1002/ejic.201500520</dc:relation>
   <dc:rights>(c) Wiley-VCH, 2015</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>29 p.</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Wiley-VCH</dc:publisher>
   <dc:source>Articles publicats en revistes (Mineralogia, Petrologia i Geologia Aplicada)</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>